Recommencement of anticoagulation in chronic subdural haematoma: a systematic review and meta-analysis

References

• Ducruet AF, Grobelny BT, Zacharia BE, et al. The surgical management of chronic subdural hematoma. Neurosurg Rev 2012;35:155–69.
   PubMed Web of Science ®Google Scholar
• Baechli H, Nordmann A, Bucher HC, Gratzl O. Demographics and prevalent risk factors of chronic subdural haematoma: results of a large single-center cohort study. Neurosurg Rev 2004;27:263–6.
   PubMed Web of Science ®Google Scholar
• Nayil K, Ramzan A, Sajad A, et al. Subdural hematomas: an analysis of 1181 Kashmiri patients. World Neurosurg 2012;77:103–10.
   PubMed Web of Science ®Google Scholar
• Lindvall P, Koskinen LO. Anticoagulants and antiplatelet agents and the risk of development and recurrence of chronic subdural haematomas. J Clin Neurosci 2009;16:1287–90.
   PubMed Web of Science ®Google Scholar
• Miranda LB, Braxton E, Hobbs J, Quigley MR. Chronic subdural hematoma in the elderly: not a benign disease. J Neurosurg 2011; 114:72–6.
   PubMed Web of Science ®Google Scholar
• Rust T, Kiemer N, Erasmus A. Chronic subdural haematomas and anticoagulation or anti-thrombotic therapy. J Clin Neurosci 2006;13:823–7.
   PubMed Web of Science ®Google Scholar
• Tang J, Ai J, Macdonald RL. Developing a model of chronic subdural hematoma. Acta Neurochir Suppl 2011;111:25–9.
   PubMedGoogle Scholar
• Torihashi K, Sadamasa N, Yoshida K, et al. Independent predictors for recurrence of chronic subdural hematoma: a review of 343 consecutive surgical cases. Neurosurgery 2008;63:1125–9.
   PubMed Web of Science ®Google Scholar
• Forster MT, Mathe AK, Senft C, et al. The influence of preoperative anticoagulation on outcome and quality of life after surgical treatment of chronic subdural hematoma. J Clin Neurosci 2010;17:975–9.
   PubMed Web of Science ®Google Scholar
• Hawryluk GW, Furlan JC, Austin JW, Fehlings MG. Survey of neurosurgical management of central nervous system hemorrhage in patients receiving anticoagulation therapy: current practice is highly variable and may be suboptimal. World Neurosurg 2011;76:299–303.
   PubMed Web of Science ®Google Scholar
• Gonugunta V, Buxton N. Warfarin and chronic subdural haematomas. Br J Neurosurg. 2001;15:514–7.
   PubMed Web of Science ®Google Scholar
• Kawamata T, Takeshita M, Kubo O, et al. Management of intracranial hemorrhage associated with anticoagulant therapy. Surg Neurol 1995;44:438–42.
   PubMedGoogle Scholar
• Yeon JY, Kong DS, Hong SC. Safety of early warfarin resumption following burr hole drainage for warfarin-associated subacute or chronic subdural hemorrhage. J Neurotrauma 2012;29:1334–41.
   PubMed Web of Science ®Google Scholar
• Santarius T, Kirkpatrick PJ, Ganesan D, et al. Use of drains versus no drains after burr-hole evacuation of chronic subdural haematoma: a randomised controlled trial. Lancet 2009;374:1067–73.
   PubMed Web of Science ®Google Scholar
• Stanisic M, Lund-Johansen M, Mahesparan R. Treatment of chronic subdural hematoma by burr-hole craniostomy in adults: influence of some factors on postoperative recurrence. Acta Neurochir (Wien) 2005;147:1249–56.
   PubMed Web of Science ®Google Scholar
• Pisters R, Lane DA, Nieuwlaat R, et al. A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. Chest 2010;138:1093–100.
   PubMed Web of Science ®Google Scholar
• Lip GY, Frison L, Halperin JL, Lane DA. Comparative validation of a novel risk score for predicting bleeding risk in anticoagulated patients with atrial fibrillation: the HAS-BLED (Hypertension, Abnormal Renal/Liver Function, Stroke, Bleeding History or Predisposition, Labile INR, Elderly, Drugs/Alcohol Concomitantly) score. J Am Coll Cardiol 2011;57:173–80.
   PubMed Web of Science ®Google Scholar
• Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest 2010;137:263–72.
   PubMed Web of Science ®Google Scholar
• Olesen JB, Lip GY, Lindhardsen J, et al. Risks of thromboembolism and bleeding with thromboprophylaxis in patients with atrial fibrillation: a net clinical benefit analysis using a ‘real world’ nationwide cohort study. Thromb Haemost 2011;106:739–49.
   PubMed Web of Science ®Google Scholar
• Butler AC, Tait RC. Restarting anticoagulation in prosthetic heart valve patients after intracranial haemorrhage: a 2-year follow-up. Br J Haematol 1998;103:1064–66.
   PubMed Web of Science ®Google Scholar
• De Vleeschouwer S, Van Calenbergh F, van Loon J, et al. Risk analysis of thrombo-embolic and recurrent bleeding events in the management of intracranial haemorrhage due to oral anticoagulation. Acta Chir Belg 2005;105:268–74.
   PubMed Web of Science ®Google Scholar
• Hawryluk GW, Austin JW, Furlan JC, et al. Management of anticoagulation following central nervous system hemorrhage in patients with high thromboembolic risk. J Thromb Haemost 2010;8:1500–8.
   PubMed Web of Science ®Google Scholar
• Majeed A, Kim YK, Roberts RS, Holmstrom M, Schulman S. Optimal timing of resumption of warfarin after intracranial hemorrhage. Stroke 2010;41:2860–6.
   PubMed Web of Science ®Google Scholar
• Phan TG, Koh M, Wijdicks EF. Safety of discontinuation of anticoagulation in patients with intracranial hemorrhage at high thromboembolic risk. Arch Neurol 2000;57:1710–13.
   PubMedGoogle Scholar
• Tahsim-Oglou Y, Beseoglu K, Hanggi D, Stummer W, Steiger HJ. Factors predicting recurrence of chronic subdural haematoma: the influence of intraoperative irrigation and low-molecular-weight heparin thromboprophylaxis. Acta Neurochir (Wien) 2012;154:1063–7.
   PubMed Web of Science ®Google Scholar
• Andersson P, Londahl M, Abdon NJ, Terent A. The prevalence of atrial fibrillation in a geographically well-defined population in northern Sweden: implications for anticoagulation prophylaxis. J Intern Med 2012;272:170–6.
   PubMed Web of Science ®Google Scholar